Feature Channels: Stem Cells

Filters close
Released: 26-Sep-2023 12:00 PM EDT
Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque
World Journal of Stem Cells

BACKGROUNDUmbilical cord (UC) mesenchymal stem cell (MSC) transplantation is a potential therapeutic intervention for atherosclerotic vascular disease. Integrin beta 3 (ITGB3) promotes cell migration in several cell types. However, whether

Released: 26-Sep-2023 12:00 PM EDT
Enhanced wound healing and hemostasis with exosome-loaded gelatin sponges from human umbilical cord mesenchymal stem cells
World Journal of Stem Cells

BACKGROUNDRapid wound healing remains a pressing clinical challenge, necessitating studies to hasten this process. A promising approach involves the utilization of human umbilical cord mesenchymal stem cells (hUC-MSCs) derived exosomes. The

Newswise: Regenerative Medicine: How Scientists Manufacture Cells
Released: 19-Sep-2023 11:05 AM EDT
Regenerative Medicine: How Scientists Manufacture Cells
Cedars-Sinai

In 1998, scientists reported being able to derive cells from human embryos that could develop into almost any cell in the body. In 2007, the field took a huge leap when scientists discovered they could reprogram human adult skin cells to act like these embryonic stem cells.

Released: 11-Sep-2023 3:05 PM EDT
Stem cell-derived components may treat underlying causes of PCOS
University of Chicago Medical Center

UChicago researchers recently unveiled a potential new PCOS treatment that restored ovarian function and improved hormonal and metabolic regulation in mice.

29-Aug-2023 5:55 PM EDT
New study shows promising evidence for sickle cell gene therapy
University of Chicago Medical Center

UChicago Medicine Comer Children’s Hospital was one of three sites to enroll patients in a clinical trial to test a potentially curative stem cell gene therapy for sickle cell disease. The results were promising.

Released: 29-Aug-2023 3:15 PM EDT
UC Davis Eye Center tests experimental gene therapy for wet age-related macular degeneration (AMD)
UC Davis Health

Ophthalmologists at UC Davis Health used an experimental gene therapy last month to treat a patient with wet age-related macular degeneration, or wet AMD. Wet AMD is a leading cause of vision loss among older adults. Glenn Yiu, a professor of ophthalmology at UC Davis Health, is the principal investigator for the new clinical trial.

Released: 26-Aug-2023 12:00 PM EDT
Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression
World Journal of Stem Cells

BACKGROUNDThe immunosuppressive capacity of mesenchymal stem cells (MSCs) is dependent on the “license” of several proinflammatory factors to express immunosuppressive factors such as programmed cell death 1 ligand 1 (PD-L1), which dete

Released: 26-Aug-2023 12:00 PM EDT
Mastering the craft: Creating an insightful and widely-cited literature review
World Journal of Stem Cells

The art of constructing an insightful literature review manuscript has witnessed an exemplar in the work of Oz et al (2023), wherein concept progression harmoniously merges with figures and tables. Reflecting on retrospective data science,

Released: 26-Aug-2023 12:00 PM EDT
Constitutive aryl hydrocarbon receptor facilitates the regenerative potential of mouse bone marrow mesenchymal stromal cells
World Journal of Stem Cells

BACKGROUNDBone marrow mesenchymal stromal cells (BMSCs) are the commonly used seed cells in tissue engineering. Aryl hydrocarbon receptor (AhR) is a transcription factor involved in various cellular processes. However, the function of const

Released: 26-Aug-2023 12:00 PM EDT
Quercetin ameliorates oxidative stress-induced senescence in rat nucleus pulposus-derived mesenchymal stem cells via the miR-34a-5p/SIRT1 axis
World Journal of Stem Cells

BACKGROUNDIntervertebral disc degeneration (IDD) is a main contributor to low back pain. Oxidative stress, which is highly associated with the progression of IDD, increases senescence of nucleus pulposus-derived mesenchymal stem cells (NPMS

Released: 26-Aug-2023 12:00 PM EDT
Wnt signaling pathway inhibitor promotes mesenchymal stem cells differentiation into cardiac progenitor cells in vitro and improves cardiomyopathy in vivo
World Journal of Stem Cells

BACKGROUNDCardiovascular diseases particularly myocardial infarction (MI) are the leading cause of mortality and morbidity around the globe. As cardiac tissue possesses very limited regeneration potential, therefore use of a potent small mo

Released: 26-Aug-2023 12:00 PM EDT
Up-to-date meta-analysis of long-term evaluations of mesenchymal stem cell therapy for complex perianal fistula
World Journal of Stem Cells

BACKGROUNDLocal mesenchymal stem cell (MSC) therapy for complex perianal fistulas (PFs) has shown considerable promise. But, the long-term safety and efficacy of MSC therapy in complex PFs remain unknown. AIMTo explore the long-term effect

Newswise: Myocardial infarction, the number one cause of sudden death, may be treated by modulating the immune response
Released: 25-Aug-2023 12:00 AM EDT
Myocardial infarction, the number one cause of sudden death, may be treated by modulating the immune response
National Research Council of Science and Technology

Dr. Yoon Ki Joung and Dr. Juro Lee of the Biomaterials Research Center at the Korea Institute of Science and Technology (KIST), together with Prof. Hun-Jun Park and Dr. Bong-Woo Park of the Catholic University of Korea College of Medicine, have developed a new treatment for myocardial infarction that uses nanovesicles derived from fibroblasts with induced apoptosis to modulate the immune response.

Newswise: Mutations in blood stem cells can exacerbate colon cancer
21-Aug-2023 9:45 AM EDT
Mutations in blood stem cells can exacerbate colon cancer
The Rockefeller University Press

Researchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.

Newswise: Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial Results
Released: 18-Aug-2023 2:10 PM EDT
Cell Therapy That Repairs Cornea Damage with Patient’s Own Stem Cells Achieves Positive Phase I Trial Results
Massachusetts Eye and Ear

Cultivated autologous limbal epithelial cells (CALEC) transplant, in which stem cells from the healthy eye and transplanted into the injured eye, for significant cornea injuries was found safe and led to gains in preliminary phase I clinical trial.

Released: 14-Aug-2023 5:00 AM EDT
A Neurogenic Signature Involving Monoamine Oxidase-A controls Human Thermogenic Adipose Tissue Development
bioRxiv

Mechanisms that control “beige/brite” thermogenic adipose tissue development may be harnessed to improve human metabolic health. To define these mechanisms, we developed a species-hybrid model in which human mesenchymal progenitor cells were used to develop white or thermogenic/beige adipose tissue in mice.

Released: 10-Aug-2023 3:50 PM EDT
Scientists reveal two paths to autism in the developing brain
Yale University

Two distinct neurodevelopmental abnormalities that arise just weeks after the start of brain development have been associated with the emergence of autism spectrum disorder, according to a new Yale-led study in which researchers developed brain organoids from the stem cells of boys diagnosed with the disorder.

Newswise: Scientists harness the power of AI to shed light on different types of Parkinson’s disease
Released: 10-Aug-2023 3:40 PM EDT
Scientists harness the power of AI to shed light on different types of Parkinson’s disease
Francis Crick Institute

Researchers at the Francis Crick Institute and UCL Queen Square Institute of Neurology, working with technology company Faculty AI, have shown that machine learning can accurately predict subtypes of Parkinson’s disease using images of patient-derived stem cells.

   
Newswise: Stem Cell Therapy Rescues Symptoms of Alzheimer’s Disease
Released: 9-Aug-2023 4:05 PM EDT
Stem Cell Therapy Rescues Symptoms of Alzheimer’s Disease
University of California San Diego

Promising preclinical results from UC San Diego show hematopoietic stem cell therapy was effective in rescuing memory loss, neuroinflammation and beta amyloid build-up in a mouse model of Alzheimer’s disease.

Newswise: New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 9-Aug-2023 10:15 AM EDT
New Chief of Pediatric Bone Marrow Transplantation and Cellular Therapies Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Niketa C. Shah, MD, as chief of Pediatric Bone Marrow Transplantation and Cellular Therapies at New Jersey’s leading cancer program.



close
2.60592